Centers for Disease Control and Prevention, 46096 [2012-18852]
Download as PDF
<![CDATA[
46096
Federal Register / Vol. 77, No. 149 / Thursday, August 2, 2012 / Notices
Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–18851 Filed 8–1–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response (BSC, OPHPR)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
9:30 a.m.–3 p.m., August 21, 2012; 9:30
a.m.–3 p.m., August 22, 2012.
Place: CDC, 1600 Clifton Road NE., Roybal
Campus, Building 19, Auditorium B2,
Atlanta, Georgia 30329.
Status: Open to the public limited only by
the space available. The meeting room will
accommodate up to 30 people. Public
participants should pre-register for the
meeting as described in Additional
Information for Public Participants.
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services (HHS), the Assistant Secretary for
Health (ASH), the Director, Centers for
Disease Control and Prevention (CDC), and
the Director, Office of Public Health
Preparedness and Response (OPHPR),
concerning strategies and goals for the
programs and research within OPHPR,
monitoring the overall strategic direction and
focus of the OPHPR Divisions and Offices,
and administration and oversight of peer
review of OPHPR scientific programs. For
additional information about the Board,
please visit: https://www.cdc.gov/phpr/
science/counselors.htm.
Matters to be Discussed: Agenda items for
this meeting include: (1) Briefings and BSC
deliberation on the following topics: OPHPR
International Activities; National Health
Security Preparedness Index Update; update
on the activities of the joint BSC-National
Biodefense Science Board Strategic National
Stockpile ad hoc working group; CDC’s
response to laboratory biosafety issues;
Public Health Emergency Medical
Countermeasure Enterprise (PHEMCE) and
CDC’s smallpox vaccine program; OPHPR’s
national policy initiatives; history and
overview of the Preparedness and Emergency
Response Learning Centers; update on CDC’s
biosurveillance and situational awareness
activities; (2) BSC liaison representative
updates to the Board highlighting
organizational activities relevant to the
OPHPR mission.
VerDate Mar<15>2010
18:15 Aug 01, 2012
Jkt 226001
Agenda items are subject to change as
priorities dictate.
Additional Information for Public
Participants: Members of the public that wish
to attend this meeting should pre-register by
submitting the following information by
email, facsimile, or phone (see Contact
Person for More Information) no later than 12
noon (EDT) on Monday, August 13, 2012:
• Full Name,
• Organizational Affiliation,
• Complete Mailing Address,
• Citizenship, and
• Phone Number or Email Address.
Contact Person for More Information:
Marquita Black, Office of Science and Public
Health Practice Executive Assistant, Centers
for Disease Control and Prevention, 1600
Clifton Road NE., Mailstop D–44, Atlanta,
Georgia 30333, telephone (404) 639–7325;
facsimile (404) 639–7977; email:
OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 27, 2012.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2012–18852 Filed 8–1–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No.FDA–2012–N–0001]
Statistical Process Controls for Blood
Establishments; Public Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
The Food and Drug Administration
(FDA) is announcing a public workshop
entitled: ‘‘Statistical Process Controls for
Blood Establishments.’’ The purpose of
this public workshop is to discuss the
implementation of statistical process
controls to validate and monitor
manufacturing processes in blood
establishments. The public workshop
has been planned in partnership with
the AABB, America’s Blood Centers,
and the Department of Health and
Human Services (HHS) Office of the
Assistant Secretary for Health. The
public workshop will include
presentations and discussions led by
experts from government and industry.
Dates and Times: The public
workshop will be held on October 19,
2012, from 8:30 a.m. to 5 p.m.
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Location: The public workshop will
be held at the FDA White Oak Campus,
The Great Room, Bldg. 31, 10903 New
Hampshire Ave. Silver Spring, MD,
20993. Please visit the following Web
site for location, parking, security, and
travel information: https://www.fda.gov/
AboutFDA/WorkingatFDA/
BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm. The public workshop
will also be available to be viewed
online via webcast.
Streaming Webcast of the Public
Workshop: For those unable to attend in
person, FDA will webcast the public
workshop. To join the web-cast of the
public workshop, please go to: https://
collaboration.fda.gov/stat101912/.
If you have never attended a Connect
Pro meeting before: Test your
connection: https://collaboration.fda.
gov/common/help/en/support/meeting_
test.htm. Get a quick overview: https://
www.adobe.com/go/connectpro_
overview.
Contact Person: Jennifer Scharpf,
Center for Biologics Evaluation and
Research (HFM–302), Food and Drug
Administration, 1401 Rockville Pike,
suite 200N, Rockville, MD 20852–1448,
301–827–6128, FAX: 301–827–2843,
email:
CBEROBRRWorkshops@fda.hhs.gov.
Registration: Mail, fax, or email your
registration information (including
name, title, firm name, address,
telephone and fax numbers, and email
address) to Jennifer Scharpf (see Contact
Person) by September 27, 2012. Please
indicate if you will attend the workshop
in person or if you will participate in
the webcast. There is no registration fee
for the public workshop. Early
registration is recommended because
seating is limited. Those who wish to
present at the workshop must attend in
person. Registration on the day of the
public workshop will be provided on a
space-available basis beginning at
7:30 a.m.
If you need special accommodations
due to a disability, please contact
Jennifer Scharpf (see Contact Person) at
least 7 days in advance.
Requests for Oral Presentations:
Interested persons are invited to make
presentations relevant to the public
workshop topic. Attendees who wish to
make presentations at the public
workshop should notify the Contact
Person and submit a brief statement of
the general nature of the presentation
before September 27, 2012.
Presentations will be scheduled on the
afternoon of October 19, 2012. Time
allotted for each presentation may be
limited depending on the number of
individuals requesting to speak.
E:\FR\FM\02AUN1.SGM
02AUN1
]]>Agencies
[Federal Register Volume 77, Number 149 (Thursday, August 2, 2012)]
[Notices]
[Page 46096]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-18852]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Public Health
Preparedness and Response (BSC, OPHPR)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates:
9:30 a.m.-3 p.m., August 21, 2012; 9:30 a.m.-3 p.m., August 22,
2012.
Place: CDC, 1600 Clifton Road NE., Roybal Campus, Building 19,
Auditorium B2, Atlanta, Georgia 30329.
Status: Open to the public limited only by the space available.
The meeting room will accommodate up to 30 people. Public
participants should pre-register for the meeting as described in
Additional Information for Public Participants.
Purpose: This Board is charged with providing advice and
guidance to the Secretary, Department of Health and Human Services
(HHS), the Assistant Secretary for Health (ASH), the Director,
Centers for Disease Control and Prevention (CDC), and the Director,
Office of Public Health Preparedness and Response (OPHPR),
concerning strategies and goals for the programs and research within
OPHPR, monitoring the overall strategic direction and focus of the
OPHPR Divisions and Offices, and administration and oversight of
peer review of OPHPR scientific programs. For additional information
about the Board, please visit: https://www.cdc.gov/phpr/science/counselors.htm.
Matters to be Discussed: Agenda items for this meeting include:
(1) Briefings and BSC deliberation on the following topics: OPHPR
International Activities; National Health Security Preparedness
Index Update; update on the activities of the joint BSC-National
Biodefense Science Board Strategic National Stockpile ad hoc working
group; CDC's response to laboratory biosafety issues; Public Health
Emergency Medical Countermeasure Enterprise (PHEMCE) and CDC's
smallpox vaccine program; OPHPR's national policy initiatives;
history and overview of the Preparedness and Emergency Response
Learning Centers; update on CDC's biosurveillance and situational
awareness activities; (2) BSC liaison representative updates to the
Board highlighting organizational activities relevant to the OPHPR
mission.
Agenda items are subject to change as priorities dictate.
Additional Information for Public Participants: Members of the
public that wish to attend this meeting should pre-register by
submitting the following information by email, facsimile, or phone
(see Contact Person for More Information) no later than 12 noon
(EDT) on Monday, August 13, 2012:
Full Name,
Organizational Affiliation,
Complete Mailing Address,
Citizenship, and
Phone Number or Email Address.
Contact Person for More Information: Marquita Black, Office of
Science and Public Health Practice Executive Assistant, Centers for
Disease Control and Prevention, 1600 Clifton Road NE., Mailstop D-
44, Atlanta, Georgia 30333, telephone (404) 639-7325; facsimile
(404) 639-7977; email: OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: July 27, 2012.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2012-18852 Filed 8-1-12; 8:45 am]
BILLING CODE 4163-18-P
